SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Walter in HK who wrote (210)3/21/1999 1:44:00 PM
From: W Shakespeare  Read Replies (3) of 413
 
As I have stated in previous posts, we are very early in the growth of the laser surgery industry. All of the major providers will make money at this early stage. The question down the road is ,"Who will be in the best strategic position once the inevitable industry shakeout and consolidation takes place?" I wish I knew the answer to that question but I do not. I can only say that I have been very impressed with the management of Laser Vision and that is why I have invested my money in that company and not elsewhere. LVCI management used the strategy of using mobile lasers in small markets to come to profitability before the other major players. They have also branched off into mobile cataract surgery. I believe LVCI has about a 10% market share (someone correct me if this figure is incorrect). IMHO, LVCI's management has consistently proven itself capable of making the correct strategic call.
I have no understanding of the Canadian market so I can make no comments about it.
The major downside of these stocks is probably the entry of a new larger competitor into the market. If this were to occur, LVCI would probably not be as severely hurt since they operate in smaller markets that would not be as attractive to a larger company. The other downside would be the discovery of some major side effect that occurs over a longer period of time. Obviously, such an event would hurt all the players equally. Finally, the adoption of a better procedure could occur. KERA and SNRS both are pushing for alternative procedures to laser surgery. I don't think KERA's insertion of a ring into the patient's eye will give hurt the laser surgery industry much. SNRS's system is not yet approved but could be a more impressive competitior.
In the long run, it all boils down to management and corporate strategy. If anyone has an understanding of LZRC and of LCAV and their management teams perhaps they could make some comments.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext